A wide variety of medical technology devices are being more rapidly reviewed and tested for patient use through the U.S. Food and Drug Administration (FDA) Breakthrough Device List. Among the list of innovations are two breast cancer diagnostic tests along with technology to improve the diagnostic of a deadly gastrointestinal condition. The breast cancer diagnostic device is a software-as-a-medical device (SAMD) said to reduce diagnosis error to less than 5%. Another device on the fast-track list is Lumicell, a medical device used to detect and remover cancerous tissue.
Read more here.
More on: News Regulatory